Lidocaine and Pain Management in First Trimester Abortions

• Status: Completed
• Trial end date: 2008-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to examine the effect of lidocaine (a numbing medication) inside the uterus on patient pain during an early abortion, compared to the paracervical block (lidocaine injected on either side of the cervix).

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Oregon Health and Science University
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Good general health

• Age>18years

• English speaking

• Voluntarily requesting pregnancy termination

• Have an estimated gestation of up to 76 days since the first day of the preceding menstrual period

• Confirmed by ultrasound

• Be able and willing to sign an informed consent

• Agree to the terms of the study

• All patients must be premedicated with Ibuprofen and Valium (per clinic protocols)

Exclusion Criteria:

• Significant physical or mental health condition

• A gestational age of 77 days or more

• Adnexal mass or tenderness on pelvic exam consistent with pelvic inflammatory disease

• Patients who require or request IV/intramuscular sedation

• Patients who refuse Ibuprofen, Valium and/or paracervical blocks

• Patients allergic to lidocaine

• Patients with known hepatic disease

• Patients weighing less than 100 lbs